Simplex Trading, LLC Aligos Therapeutics, Inc. Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$0.35 - $1.07 $313 - $958	-896 Reduced 81.16%	208 $0
Q1 2024 Apr 25, 2024	BUY	$0.64 - $1.13 $706 - $1,247	1,104 New	1,104 $1,000
Q2 2023 Aug 04, 2023	SELL	$0.89 - $1.36 $347 - $530	-390 Reduced 24.7%	1,189 $1,000
Q1 2023 Apr 27, 2023	BUY	$0.87 - $2.11 $1,373 - $3,331	1,579 New	1,579 $1,000
Q2 2022 Aug 03, 2022	SELL	$1.04 - $2.14 $1,345 - $2,769	-1,294 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$2.08 - $12.2 $2,691 - $15,786	1,294 New	1,294 $2,000

227K

Ticker ALGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,717,000
Market Cap $1.28B
Description
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB);...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.